IGC Pharma Inc (IGC) concluded trading on Wednesday at a closing price of $0.37, with 20.58 million shares of worth about $7.61 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.52% during that period and on July 09, 2025 the price saw a gain of about 15.24%. Currently the company’s common shares owned by public are about 80.88M shares, out of which, 57.25M shares are available for trading.
Stock saw a price change of 20.59% in past 5 days and over the past one month there was a price change of 19.37%. Year-to-date (YTD), IGC shares are showing a performance of -9.64% which increased to 8.93% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.25 but also hit the highest price of $0.50 during that period. The average intraday trading volume for IGC Pharma Inc shares is 227.23K. The stock is currently trading 18.28% above its 20-day simple moving average (SMA20), while that difference is up 18.63% for SMA50 and it goes to 10.43% higher than SMA200.
IGC Pharma Inc (AMEX: IGC) currently have 80.88M outstanding shares and institutions hold larger chunk of about 3.41% of that.
The stock has a current market capitalization of $30.70M and its 3Y-monthly beta is at 1.47. It has posted earnings per share of -$0.09 in the same period. It has Quick Ratio of 0.68 while making debt-to-equity ratio of 0.04. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IGC, volatility over the week remained 6.93% while standing at 4.51% over the month.
Analysts are in expectations that IGC Pharma Inc (IGC) stock would likely to be making an EPS of -0.03 in the current quarter, while forecast for next quarter EPS is -0.03 and it is -0.12 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.03 which is -0.02 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.03 in the same quarter a year ago.
